These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 25887079)
1. Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy. Gunjal PM; Schneider G; Ismail AA; Kakar SS; Kucia M; Ratajczak MZ J Ovarian Res; 2015 Mar; 8():20. PubMed ID: 25887079 [TBL] [Abstract][Full Text] [Related]
2. Induction of a Tumor-Metastasis-Receptive Microenvironment as an Unwanted Side Effect After Radio/Chemotherapy and In Vitro and In Vivo Assays to Study this Phenomenon. Schneider G; Sellers ZP; Ratajczak MZ Methods Mol Biol; 2016; 1516():347-360. PubMed ID: 27032941 [TBL] [Abstract][Full Text] [Related]
3. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment. Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725 [TBL] [Abstract][Full Text] [Related]
4. [Alteration of metastatic potential of ovarian cancer in clinical course]. Kamura T Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):607-17. PubMed ID: 8808828 [TBL] [Abstract][Full Text] [Related]
5. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
6. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells. Govaert KM; Emmink BL; Nijkamp MW; Cheung ZJ; Steller EJ; Fatrai S; de Bruijn MT; Kranenburg O; Borel Rinkes IH Ann Surg; 2014 Apr; 259(4):750-9. PubMed ID: 24253142 [TBL] [Abstract][Full Text] [Related]
8. Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells. Schneider G; Glaser T; Lameu C; Abdelbaset-Ismail A; Sellers ZP; Moniuszko M; Ulrich H; Ratajczak MZ Mol Cancer; 2015 Nov; 14():201. PubMed ID: 26597723 [TBL] [Abstract][Full Text] [Related]
9. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment. Kerbel RS Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079 [TBL] [Abstract][Full Text] [Related]
10. Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy. Ratajczak MZ; Jadczyk T; Schneider G; Kakar SS; Kucia M J Ovarian Res; 2013 Dec; 6(1):95. PubMed ID: 24373588 [TBL] [Abstract][Full Text] [Related]
11. Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model. Lin KT; Sun SP; Wu JI; Wang LH PLoS One; 2017; 12(6):e0178937. PubMed ID: 28591224 [TBL] [Abstract][Full Text] [Related]
12. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis. Singh A; Veeriah V; Xi P; Labella R; Chen J; Romeo SG; Ramasamy SK; Kusumbe AP JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292293 [TBL] [Abstract][Full Text] [Related]
13. A novel mouse model of gastric cancer with human gastric microenvironment. Zheng MJ; Wang J; Chen YW; Xu L; Xue DD; Fu W; Zhang YF; Du Q; Zhao Y; Ling LJ; Ding Q; Liu XA; Zha XM; Zheng W; Xia TS; Wang S Cancer Lett; 2012 Dec; 325(1):108-15. PubMed ID: 22750094 [TBL] [Abstract][Full Text] [Related]
14. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers. Chi JY; Hsiao YW; Li CF; Lo YC; Lin ZY; Hong JY; Liu YM; Han X; Wang SM; Chen BK; Tsai KK; Wang JM Oncotarget; 2015 Sep; 6(27):23987-4001. PubMed ID: 26124179 [TBL] [Abstract][Full Text] [Related]
15. SCID-hu mice for the study of human cancer metastasis. Namikawa R; Shtivelman E Cancer Chemother Pharmacol; 1999; 43 Suppl():S37-41. PubMed ID: 10357557 [TBL] [Abstract][Full Text] [Related]
16. Dequalinium blocks macrophage-induced metastasis following local radiation. Timaner M; Bril R; Kaidar-Person O; Rachman-Tzemah C; Alishekevitz D; Kotsofruk R; Miller V; Nevelsky A; Daniel S; Raviv Z; Rotenberg SA; Shaked Y Oncotarget; 2015 Sep; 6(29):27537-54. PubMed ID: 26348470 [TBL] [Abstract][Full Text] [Related]
17. Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone. Kolonin MG; Sergeeva A; Staquicini DI; Smith TL; Tarleton CA; Molldrem JJ; Sidman RL; Marchiò S; Pasqualini R; Arap W Cancer Res; 2017 Jun; 77(12):3144-3150. PubMed ID: 28428279 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model. Liu R; Zheng H; Li W; Guo Q; He S; Hirasaki Y; Hou W; Hua B; Li C; Bao Y; Gao Y; Qi X; Pei Y; Zhang Y J Transl Med; 2015 Nov; 13():366. PubMed ID: 26597177 [TBL] [Abstract][Full Text] [Related]
19. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997 [TBL] [Abstract][Full Text] [Related]
20. Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironment. Trenti A; Boscaro C; Tedesco S; Cignarella A; Trevisi L; Bolego C Biochem Pharmacol; 2018 Aug; 154():414-423. PubMed ID: 29890142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]